Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/20222840
Conclusion of this study
Both metformin and MYO, can be considered as first line treatment for restoring normal menstrual cycles in most patients with PCOS, even if MYO treatment seems to be more effective than metformin.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study